Thalidomide
| Use attributes for filter ! | |
| Formula | C13H10N2O4 |
|---|---|
| IUPAC ID | (RS)-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione |
| Molar mass | 258. 23 g/mol |
| Other names | α-Phthalimidoglutarimide |
| Chirality | Racemic mixture |
| Elimination half-life | 5–7. 5 hours (dose-dependent) |
| License data | EMA |
| US | |
| FDA | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2225739 |
About Thalidomide
Thalidomide, sold under the brand name Thalomid among others, is a medication used to treat a number of cancers including multiple myeloma, graft-versus-host disease, and a number of skin conditions including complications of leprosy.